These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 605427)

  • 1. [Antidysrhythmic effects of procainamide derivatives].
    Guerin ML; Morin H
    Therapie; 1977; 32(4):501-15. PubMed ID: 605427
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiarrhythmic structure activity relationships in a series of lidocaine procainamide derivatives.
    Ehring GR; Hondeghem LM
    Proc West Pharmacol Soc; 1981; 24():221-4. PubMed ID: 7255453
    [No Abstract]   [Full Text] [Related]  

  • 3. A new series of antiarrhythmic procainamide derivatives: toxicity and activity-simulated passive absorption relation.
    Brazier M; Lefebvre C; Robert H; Reynaud P; Nguyen-Tri-Xuong E; Arnould-Guérin ML; Pieri F
    Farmaco; 1990 Dec; 45(12):1351-9. PubMed ID: 2090144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis of N-phenylmaleimides. Kinetics of the antifibrillatory action of a derivative of procainamide].
    Luu-Duc C; Marsura A; Charlon C; Merle D; Mazin D
    Farmaco Sci; 1985 Apr; 40(4):253-8. PubMed ID: 4018251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclovinylogues of procainamide.
    Valenti P; Mazzotti M; Rampa A; Magistretti MJ
    Arch Pharm (Weinheim); 1982 Dec; 315(12):1003-7. PubMed ID: 7159188
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary evaluation of the anti-arrhythmia effect of 4-acylamino-N[2-diethylaminoethyl]benzamides (N-acyl derivatives of procainamide)].
    Kusowska J; Sienkiewicz J
    Acta Pol Pharm; 1985; 42(4):367-73. PubMed ID: 2422880
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of antiarrhythmic effects of procainamide, N-acetylprocainamide, and p-hydroxy-N-(3-diethylaminopropyl)benzamide.
    Reynolds RD; Burmeister WE; Calzadilla SV; Lee RJ; Reidenberg MM; Drayer DE
    Proc Soc Exp Biol Med; 1982 Feb; 169(2):156-60. PubMed ID: 6174988
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of the effects of disopyramide and procainamide on auriculo-ventricular conduction in dogs under chloralose].
    Duchêne-Marullaz P; Schaff G; Lapalus P; Lautier F; Lavarenne P
    C R Seances Soc Biol Fil; 1970 Sep; 164(2):327-9. PubMed ID: 4249123
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative structure activity studies of antiarrhythmic properties in a series of lidocaine and procainamide derivatives.
    Ehring GR; Moyer JW; Hondeghem LM
    J Pharmacol Exp Ther; 1988 Feb; 244(2):479-92. PubMed ID: 2450194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the dromotropic effects of disopyramide, dihydroquinidine and procainamide].
    Duchene-Marullaz P; Schaff G; Lavarenne J; Lautier F; Lapalus P
    Therapie; 1971; 26(1):89-95. PubMed ID: 5554771
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of the electrophysiological and antiarrhythmic properties of the N-acetyl metabolite of procainamide with plasma and tissue drug concentrations in the dog.
    Bagwell EE; Walle T; Drayer DE; Reidenbert MM; Pruett JK
    J Pharmacol Exp Ther; 1976 Apr; 197(1):38-48. PubMed ID: 1263131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchodilator substances. Part 1: synthesis and structure-activity relationships between new benzoic and heterocyclic amide derivatives.
    Regnier GL; Canevari RJ; Duhault JL; Laubie ML
    Arzneimittelforschung; 1974 Dec; 24(12):1969-70. PubMed ID: 4480358
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Comparison of the effects of mexiletine, lignocaine and procainamide on canine Purkinje fibres.
    Allen JD; Arnold JM
    J Physiol; 1974 Jan; 236(1):26P-28P. PubMed ID: 4818502
    [No Abstract]   [Full Text] [Related]  

  • 15. Is the antiarrhythmic effects of PA related to wavelength?
    Tribulova N; Manoach M
    Circulation; 1999 Apr; 99(16):2220-1. PubMed ID: 10217701
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of desethyl procainamide in patients: a new metabolite of procainamide.
    Ruo TI; Morita Y; Atkinson AJ; Henthorn T; Thenot JP
    J Pharmacol Exp Ther; 1981 Feb; 216(2):357-62. PubMed ID: 6162026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of active antiarrhythmia substances on refractory period and contractility of guinea pig atria].
    Heeg E; Reuter N; Steiger H
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):244-5. PubMed ID: 4243341
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of 6,7-dimethoxycoumarin on experimental arrhythmia].
    Du GY; Ye WH; Lü F; Jing HD
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14 Suppl():S16-8. PubMed ID: 8010065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new anti-arrhythmia drug. I. Study of the anti-arrhythmia effects of a new N-acyl derivative of procainamide in rabbits].
    Kusowska J
    Acta Pol Pharm; 1988; 45(4):346-50. PubMed ID: 3245471
    [No Abstract]   [Full Text] [Related]  

  • 20. Rate-dependent effects of sematilide on action potential duration in isolated guinea pig ventricular myocytes.
    Sawanobori T; Adaniya H; Namiki T; Hiraoka M
    J Pharmacol Exp Ther; 1994 Oct; 271(1):302-10. PubMed ID: 7965729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.